silybin has been researched along with taurochenodeoxycholic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basiglio, CL; Mottino, AD; Roma, MG; Sánchez Pozzi, EJ | 1 |
| Aa, J; Sun, R; Wang, G; Wei, Q; Xie, Y; Xu, D; Zhang, B | 1 |
2 other study(ies) available for silybin and taurochenodeoxycholic acid
| Article | Year |
|---|---|
Differential effects of silymarin and its active component silibinin on plasma membrane stability and hepatocellular lysis.
Topics: Animals; Cell Membrane; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatocytes; Male; Octoxynol; Rats; Rats, Wistar; Silybin; Silymarin; Taurochenodeoxycholic Acid | 2009 |
Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model.
Topics: Animals; Cholesterol, Dietary; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Lipid Metabolism; Liver; Male; Metabolomics; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Silybin; Taurochenodeoxycholic Acid | 2020 |